Key facts
- This page summarizes Corey McCann's Form 4 filing for Pear Therapeutics, Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Feb 2023, 15:12.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of PEAR Class A Common Stock.
Footnote F2
The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026.